Skip to content

Neuroplasticity: all studies

Page 177 of 178: studies 1,761 to 1,770 of 1,773, newest first. Back to the neuroplasticity overview

Research

Changes in brain structure and function following exposure to oral LSD during adolescence: A multimodal MRI study

Lila Harris, Zachary Smith, Richard J. Ortiz et al. preprint

Abstract Background: LSD is a hallucinogen with complex neurobiological and behavioral effects. Underlying these effects are changes in brain neuroplasticity. This is the first study to follow the developmental changes in brain structure and function following LSD exposure in periadolescence. Methods: Female and male mice were given vehicle, single or multiple treatments of 3.3 µg of LSD by...

An Oral "Ketamine-Like" NMDA/AMPA Modulation Stack Restores Cognitive Capacity in a Young Man with Schizoaffective Disorder—Case Report

Ngo Cheung preprint

Cognitive impairment—rather than psychosis or mood instability—often drives long-term disability in schizoaffective disorder, yet current antipsychotic and mood-stabilising regimens offer little relief. We describe a 22-year-old man with schizoaffective disorder, bipolar type, whose persistent "brain fog" jeopardised university graduation despite euthymic mood and quiescent psychosis on...

Improved Wellbeing and Resilience via Breathwork Interventions for Computer Workers

Cristina Martinez Montes, Birgit Penzenstadler preprint

Abstract Context: Individual sustainability is undermined by continuous stress, a circumstance many software developers and computer workers are constantly exposed to via deadlines, over-commitment, and high workload. Purpose: We analyze the experience of IT workers when using a deep breathing practice to improve wellbeing, considering their perception of impacts in both benefits and...

Exploring the Impact of Behaviour Modification: Observing Human Brain Chemical Neurotransmitter Changes and their Influence on Behaviour Abstract This research explores the effects of meditation on stress management and mental health. Meditation is a widely practiced technique known for its positive impact on various physiological systems, particularly those involved in depression. While its therapeutic benefits are recognized, the precise mechanisms through which meditation operates remain unclear. This study delves into the physiological abnormalities associated with stress-mediated depression and how different meditation techniques can reverse these anomalies. The focus is on the endocrine system's role, including axes like hypothala (Preprint)

Nakul Kumar

BACKGROUND Organic chemistry and biological applications of the newly synthesized organic molecules OBJECTIVE To identify the effects of neurotransmitter and the effects of chemical imbalance in human brain METHODS Literature study, Experimental and analysis RESULTS The effects of the chemical imbalance are highly responsible for many neurotransmitter disease. CONCLUSIONS In conclusion,...

MAP training: combining meditation and aerobic exercise reduces depression and rumination while enhancing synchronized brain activity

Brandon L Alderman, Ryan L Olson, C.J. Brush et al.

Mental and physical (MAP) training is a novel clinical intervention that combines mental training through meditation and physical training through aerobic exercise. The intervention was translated from neuroscientific studies indicating that MAP training increases neurogenesis in the adult brain. Each session consisted of 30 min of focused-attention (FA) meditation and 30 min of...

Contribution of REM sleep and N2 sleep spindles to procedural memory consolidation in Vipassana meditators and non-meditating controls.

Elizaveta Solomonova, Simon Dubé, Cloé Blanchette-Carrière et al.

Study objectives: Rapid eye movement (REM) sleep, non-rapid eye movement (NREM) sleep, and sleep spindles are all implicated in the consolidation of procedural memories. The relative contributions of sleep stages and sleep spindles was previously shown to depend on individual differences in task processing. Experience with Vipassana meditation is one such individual difference that has not been...

Effects of a Neuroscience-Based Mindfulness Meditation Program on Psychological Health (Preprint)

Julia C. Basso, Sarah Lynn

BACKGROUND Mindfulness and meditation have a rich historical tradition, and a growing scientific base of evidence supports their use in creating positive psychological and neuroplastic changes for practitioners. Though meditation can be taught in various ways, the scientific community has yet to systematically study different types of meditation on neuropsychological outcomes, especially as it...

Meditation as a Tool for Symptom Relief in Schizophrenia: Bridging Neuroscience and Mental Health

H. Aung, S. Yati

Background: Schizophrenia, characterized by symptoms such as auditory and visual hallucinations, imposes significant challenges on mental health care. Recent research highlights the potential of meditation to alleviate symptoms by enhancing emotional regulation and neuroplasticity. This study examines the role of meditation as an adjunctive therapy for schizophrenia, exploring its...

Improvement in Depressive Symptoms in a Patient with Severe and Enduring Anorexia Nervosa and Comorbid Major Depressive Disorder Using Psychotherapy-Assisted IV Ketamine : A Case Report

Amanda Timek, Catherine Daniels-Brady, Stephen Ferrando preprint

Abstract Background : Anorexia nervosa is a life-threatening psychiatric illness with a high mortality rate and limited treatment options. This illness is frequently comorbid with major depressive disorder, leading to additional obstaces in patient quality of life, and increasing the mortality rate further due to risk of suicide. Ketamine, an competitive N-methyl-D-aspartate receptor...

Concurrent Changes in Self-Reported Sleep Disturbance During At-Home Ketamine-Assisted Therapy for Depression: A Retrospective Analysis of 13,963 Adults

Research Square Jack Swain, Davis Carter, Leonardo Vando et al. preprint

Abstract Background Sleep disturbances are a significant public health burden affecting 50 to 70 million adults in the United States and contributing to impaired cognition, accelerated disease progression, and increased mortality risk. 1,2 Available pharmacological treatments carry notable safety and tolerability risks, while access to the leading evidence-based behavioral intervention,...